• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于肌肉骨骼肉瘤手术分期的系统。

A system for the surgical staging of musculoskeletal sarcoma.

作者信息

Enneking W F, Spanier S S, Goodman M A

出版信息

Clin Orthop Relat Res. 1980 Nov-Dec(153):106-20.

PMID:7449206
Abstract

A surgical staging system for musculoskeletal sarcomas stratifies bone and soft-tissue lesions of any histogenesis by the grade of biologic aggressiveness, by the anatomic setting, and by the presence of metastasis. The three stages: I--low grade; II--high grade; and III--presence of metastases, are subdivided by (a) whether the lesion is anatomically confined within well-delineated surgical compartments, or (b) beyond such compartments in ill-defined fascial planes and spaces. Operative margins are defined as intralesional, marginal, wide, and radical, and relate the surgical margin to the lesions, its reactive zone, and anatomic compartment. The system defines prognostically significant progressive stages of risk which also have surgical implications. When the system is linked to clearly defined surgical procedures, it permits appropriate evaluation and comparison of the new treatment protocols designed to replace standard surgical treatment.

摘要

一种用于肌肉骨骼肉瘤的手术分期系统,根据生物侵袭性等级、解剖位置以及有无转移,对任何组织发生类型的骨和软组织病变进行分层。三个阶段:I期——低级别;II期——高级别;III期——存在转移,再根据以下情况细分:(a) 病变在解剖学上是否局限于界限清楚的手术分区内,或 (b) 是否超出此类分区,位于界限不清的筋膜平面和间隙中。手术切缘定义为病灶内、边缘、广泛和根治性切缘,将手术切缘与病变、其反应区和解剖分区相关联。该系统定义了具有预后意义的风险进展阶段,这也具有手术意义。当该系统与明确界定的手术程序相关联时,它允许对旨在取代标准手术治疗的新治疗方案进行适当的评估和比较。

相似文献

1
A system for the surgical staging of musculoskeletal sarcoma.一种用于肌肉骨骼肉瘤手术分期的系统。
Clin Orthop Relat Res. 1980 Nov-Dec(153):106-20.
2
[Evaluation method of surgical margin in musculoskeletal sarcoma].[骨肉瘤手术切缘的评估方法]
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1802-10.
3
A system of staging musculoskeletal neoplasms.肌肉骨骼肿瘤分期系统。
Clin Orthop Relat Res. 1986 Mar(204):9-24.
4
[Staging of musculoskeletal sarcomas (author's transl)].肌肉骨骼肉瘤的分期(作者译)
Acta Chir Orthop Traumatol Cech. 1982 Apr;49(2):160-5.
5
Current concepts review. The surgical staging of musculoskeletal sarcoma.当前概念综述。肌肉骨骼肉瘤的外科分期
J Bone Joint Surg Am. 1980 Sep;62(6):1027-30.
6
A comparison study of staging systems for bone sarcomas.骨肉瘤分期系统的比较研究。
Clin Orthop Relat Res. 2003 Oct(415):64-71. doi: 10.1097/01.blo.0000093898.12372.6c.
7
Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.原发性腹膜后软组织肉瘤临床适用术后分类系统的评估
Ann Surg Oncol. 2004 May;11(5):483-90. doi: 10.1245/ASO.2004.09.005. Epub 2004 Apr 12.
8
A system of staging musculoskeletal neoplasms.肌肉骨骼肿瘤分期系统。
Instr Course Lect. 1988;37:3-10.
9
Surgical theory, staging, definition and treatment of musculoskeletal sarcomas.肌肉骨骼肉瘤的手术理论、分期、定义及治疗
Surg Clin North Am. 1983 Jun;63(3):671-96. doi: 10.1016/s0039-6109(16)43036-7.
10
Staging of musculoskeletal neoplasms. Musculoskeletal Tumor Society.肌肉骨骼肿瘤的分期。肌肉骨骼肿瘤学会。
Skeletal Radiol. 1985;13(3):183-94. doi: 10.1007/BF00350572.

引用本文的文献

1
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS).手术联合化疗治疗毛细血管扩张性骨肉瘤:来自骨肉瘤协作研究组(COSS)的223例患者报告
Cancer Med. 2025 Sep;14(17):e71211. doi: 10.1002/cam4.71211.
2
Metastatic Adamantinoma of Fibula to the Lungs: A Rare Case Report.腓骨转移性造釉细胞瘤至肺:一例罕见病例报告
Int Med Case Rep J. 2025 Jul 18;18:909-914. doi: 10.2147/IMCRJ.S535403. eCollection 2025.
3
A New Relevant Integrated Radiologic and Surgical Classification Scheme for Giant Cell Tumors of Bones.
一种新的骨巨细胞瘤相关综合放射学与外科学分类方案。
J Am Acad Orthop Surg Glob Res Rev. 2025 Jul 17;9(7). doi: 10.5435/JAAOSGlobal-D-24-00321. eCollection 2025 Jul 1.
4
Prognostic factors and treatment outcomes of malignant peripheral nerve sheath tumors (MPNST) of the extremities: A tertiary cancer institutional analysis.肢体恶性外周神经鞘膜瘤(MPNST)的预后因素及治疗结果:一项三级癌症机构分析。
J Orthop. 2025 May 31;70:196-201. doi: 10.1016/j.jor.2025.05.054. eCollection 2025 Dec.
5
As Radical as Technically Feasible-Surgical Treatment for Mobile Spine Chordoma.技术可行范围内的激进治疗——可移动性脊柱脊索瘤的外科治疗
Cancers (Basel). 2025 Jun 14;17(12):1989. doi: 10.3390/cancers17121989.
6
Cystic bone Lesions: Diagnostic pitfalls and therapeutic considerations.囊性骨病变:诊断陷阱与治疗考量
J Clin Orthop Trauma. 2025 May 5;67:103046. doi: 10.1016/j.jcot.2025.103046. eCollection 2025 Aug.
7
The Impact of Resection Margins in Primary Resection of High-Grade Soft Tissue Sarcomas: How Far Is Far Enough?切缘在高级别软组织肉瘤初次切除中的影响:多远才算足够?
Biomedicines. 2025 Apr 22;13(5):1011. doi: 10.3390/biomedicines13051011.
8
Surgical Treatment and Prognosis of Soft Tissue Sarcoma in Patients Aged 85 Years and Older.85岁及以上患者软组织肉瘤的外科治疗与预后
In Vivo. 2025 May-Jun;39(3):1661-1668. doi: 10.21873/invivo.13967.
9
Partial sacrectomy with en bloc tumor resection without instrumentation. What level is safe?不使用内固定器械进行整块肿瘤切除的部分骶骨切除术。安全的切除平面是什么?
Brain Spine. 2025 Mar 27;5:104246. doi: 10.1016/j.bas.2025.104246. eCollection 2025.
10
Bone Regeneration: A Review of Current Treatment Strategies.骨再生:当前治疗策略综述
J Clin Med. 2025 Mar 8;14(6):1838. doi: 10.3390/jcm14061838.